(Abst.) IV ofatumumab treatment of MS and related disorders... on: October 25, 2022, 09:20:47 pm #1 From PubMed (October 25, 2022)--"Intravenous ofatumumab treatment of multiple sclerosis and related disorders: An observational study": Intravenous ofatumumab treatment of multiple sclerosis and related disorders: An observational study - PubMed Our data indicate a reduction of relapse frequency, stabilization of disability worsening and an acceptable safety profile, although we observed a higher frequency of infusion reactions compared to... PubMed · pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
